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strated a uterine intramural/subserosal nodule compatible with
leiomyoma. Laboratory data was unremarkable. The patient underwent
transabdominal myomectomy and the excision of the tumor (with a
jelly-like gross appearance) was fractionated and incomplete. Macro-
scopic examination showed amyxoid fragmentedmass.Microscopically,
the neoplasm was characterized as a mesenchymal tumor, with spindle
cells on a myxoid stroma with alternating hyper- and hypocellular
areas (Fig. 1A). Hemangiopericytoma-like vessels were also described
(Fig. 1D). Mytotic rate was 4 per 10 high power ﬁelds (Fig. 1C). There
were no necrotic areas. Immunohistochemical analysis showed that theIntroduction
Uterine sarcomas encompass a broad spectrum of neoplasms that
range frompuremesenchymal tumors and endometrial stromal tumors
to mixed epithelial/stromal tumors. Although several classiﬁcation
systems are available, they are all based upon the World Health
Organization histologic classiﬁcation system of uterine mesenchymal
tumors. Formerly believed to be restricted to the pleura, solitary ﬁbrous
tumors (SFTs) have been increasingly recognized in extrapulmonary
sites (Morimitsu et al., 2000; Vallat-Decouvelare et al., 1998). In the
female genital tract they are extremely rare and there are only scarce
reports in the literature (Berzal-Cantalejo et al., 2005). Typical histolog-
ic features of SFTs include haphazardly arranged spindle cells, alternat-
ing hypocellular and hypercellular areas, collagenous stroma, and
thin-walled branching blood vessels (Morimitsu et al., 2000;
Vallat-Decouvelare et al., 1998; Berzal-Cantalejo et al., 2005). Although
myxoid change is not an uncommon ﬁnding in SFTs, thosewith a prom-
inent myxoid stroma are quite rare (De Saint Aubain Somerhausen et
al., 1999; Lau et al., 2009).Case report
A 30-year-old woman presented with diffuse abdominal pain and
menorrhagia for the last four months. Physical examination revealedcs and Gynecology, Unidade
o da Maternidade 4050‐371,
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-ND license .neoplastic cells were diffusely immunoreactive for CD 34, CD 99, and
bcl2 (Fig. 2); they were negative for CAM 5.2, HHF-35, smooth muscle
actin, CD 10, S-100 and desmin. Histological and immunohistochemical
features suggested a myxoid malignant SFT of the uterus. Brain mag-
netic resonance imaging (MRI), thoracic, abdominal and pelvic com-
puted tomography (CT) scans excluded the presence of extra-pelvic
neoplastic sites and metastasis. Hysterectomy with bilateral adnexal
conservation was performed afterwards. Histological examination
showed persistence of the myxoid SFT previously described, with in-
ﬁltrative growth towards the myometrium. Currently the patient is
being followed (50 months after the surgery) and all radiographic
data shows no evidence of disease.
Discussion
SFTs are uncommonneoplasms. Initially identiﬁed as a distinct pleu-
ral lesion, SFTs are tumors of ubiquitous location and they were
described at various extrapleural sites. In the female tract, SFT is ex-
tremely uncommon (Berzal-Cantalejo et al., 2005). Usually, patients
range from 20 to 70 years. Symptoms, if present, include painless swell-
ing, menorrhagia, ﬂank pain or pelvic fullness. One uterine SFT was as-
sociated with severe hypoglycemia due to insulin-like growth factor II
production (Vallat-Decouvelare et al., 1998). Myxoid change is a com-
mon, though generally focal ﬁnding in SFTs. In contrast, SFTs exhibiting
a predominantly myxoid stroma are rarely encountered. The histologic
features of myxoid solitary ﬁbrous tumor are relatively nonspeciﬁc and
include the presence of abundant, pale myxoid matrix, prominent,
branching, staghorn-like (hemangiopericytoma-like) blood vessels,
and a “patternless pattern” growth of spindled cells, with alternating
hyper- and hypocellular areas (De Saint Aubain Somerhausen et al.,
1999; Lau et al., 2009). Similar to conventional SFT, by immunohisto-
chemistry, the myxoid variant commonly expresses CD34, CD99, and
bcl-2, and is typically negative for keratin, epithelial membrane antigen
(EMA), S-100 protein, andmuscle-associated antigens (Lau et al., 2009).
Fig. 1. A — Hypercellular areas alternating with myxoid dominant areas (H&E stain, 40×). B— Perivascular hyalinization (H&E stain, 200×). C —Mitotic activity (black arrows, H&E
stain, 400×). D — Collagenous bundles, rosettes and hemangiomapericytoma-like vascular pattern (H&E stain, 200×).
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broad, and includes the myxoid variant of other spindle cell neoplasms
such as low grade ﬁbrosarcoma, ﬁbrosarcomas, synovial sarcomas,
leiomyomas, leiomyosarcomas, liposarcomas, and nerve sheath tu-
mors; all of these neoplasms are generally CD34 negative. Low-grade ﬁ-
brosarcoma contains myxoid areas and cytologically, spindle cells of
this tumor adopt a characteristic whorled or swirling growth pattern
not seen in myxoid SFT (Lau et al., 2009). The presence of multinodular
growthwith ﬁbrous septa, cells with atypical hypercromatic nuclei andFig. 2. Immunohistochemistry of the spindle cellsmucin containing pseudolipoblasts are diagnostic hallmarks of
myxoﬁbrosarcomas (Lau et al., 2009). Myxoid synovial sarcoma can
be distinguished frommyxoid SFT because it is usually immunoreactive
for keratin and epithelial membrane antigen (EMA) (Lau et al., 2009).
Myxoid leiomyoma and leiomyosarcomas typically show positivity for
desmin, actin and smooth muscle actin, which are generally not
detected in myxoid SFT (Table 1). Myxoid liposarcoma is separable
from myxoid SFT by the presence of lipoblasts, an arborizing capillary
vasculature and pools of stromal mucine. Nerve sheath tumors andrevealed the expression of CD 34 and BCL2.
Table 1
Histology and staining patterns of leiomyomas, leiomyosarcomas and SFTs.
Histology Immunohistochemistry
Leiomyoma Fascicles of elongated spindle cells
with ovoid, “cigar-shaped” nuclei and
eosinophilic cytoplasm
Desmin (+)
h-Caldesmon (+)
HDAC8 (+)
Smooth muscle actin
(+)
CD10 (+/−)
Leiomyosarcoma Hypercellular, fascicular growth;
areas of hypocellularity may be
present
Elongated spindle cells
Tumor cell necrosis
Mitotic index≥10/10 HPF
Diffuse moderate to severe cytologic
atypia
Desmin (+)
h-Caldesmon (+)
Smooth muscle actin
(+)
SFT Patternless growth with alternating
hyper- and hypocellular areas
Abundant pale myxoid matrix
Prominent, branching, staghorn-like
blood vessels
(hemangiopericytoma-like)
Desmin (−)
Smooth muscle actin
(−)
h-Caldesmon (−)
CD 10 (−)
CD 34 (+)
bcl2 (+)
Vimentin (+)
CD 99 (+/−)
145J. Casanova et al. / Gynecologic Oncology Reports 2 (2012) 143–145especially malignant peripheral nerve sheath tumor are S-100 protein
positive in one half of the cases (myxoid SFTs are generally negative
for this marker).
The biological behavior of extrapleural SFT has been regarded as
unpredictable (Morimitsu et al., 2000; Vallat-Decouvelare et al.,
1998; Berzal-Cantalejo et al., 2005; De Saint Aubain Somerhausen etal., 1999; Lau et al., 2009; Hasegawa et al., 1999). Some tumors with
atypical histological features (such as, nuclear atypia, inﬁltrative mar-
gins, high cellularity, increased mytotic rate and foci of hemorrhage
and necrosis) did not behave aggressively and other tumors without
any atypical histologic features developed local recurrence or
distant metastasis (Morimitsu et al., 2000; De Saint Aubain
Somerhausen et al., 1999; Hasegawa et al., 1999). Due to the lack
of clinical information concerning the behavior of myxoid SFT and
the histologic ﬁndings in this particular case, extended follow-up
is required. After our research (English literature), we found no
other case of a malignant myxoid SFT of the uterus with a mainly in-
tramural location.
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